Smithsonian Magazine on MSN
A new trial put immune system-boosting therapies to the test to fight HIV, raising hopes for keeping the virus at bay
After receiving a series of immunotherapies, most people with HIV in a small study kept their virus levels low for several ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...
The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be ...
3don MSN
Common water pill may help HIV medicines work faster and reduce inflammation, early study suggests
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful ...
A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, ...
Maine is working with the Centers for Disease Control and Prevention to address an HIV outbreak in the northern part of the ...
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback